Fields & Applications

Axolabs’ Ingo Röhl takes us back to the early days of oligonucleotides, through a pandemic, to the promise of tomorrow

We asked Tadhg Devlin, Bioprocessing Trainer at NIBRT, to provide an overview on the basics of peptide mapping – a crucial quality control step

Welcome to the sixth and final chapter of “So You Want to Be a Biopharmaceutical Analyst”

Peter O’Byrne, Bioprocessing Trainer, NIBRT, explores the wonder – and complexity – of monoclonal antibodies

If you thought a monoclonal antibody was complex, what if we connect it to a potent cytotoxic drug with a special linker molecule?

Lingjun Li shares insights into AI-driven multiomics and the future of disease diagnosis and treatment

We spoke with KNAUER’s Ulrike Krop to learn more about the company’s systematic and cost-saving approach to scale-up

Thomas Dutriez talks 2D trends, demystifying GC×GC, and gives us a sneak preview of his upcoming talk

Andrew Ault reveals the biggest challenges and opportunities in environmental analysis and how we can make air monitoring accessible globally

How will analytical science transform how we diagnose and treat over the next 20 years? We asked five Human Health Pioneers.